Reports in March 2020 suggested new loss of smell as one of the symptoms of COVID-19. We here implemented a method that could use a straightforward collection of written comments describing changes in smell perception to reveal characteristics and predict who was infected by the SARS-CoV-2 virus
Proteomic analysis of COVID-19-associated Acute Kidney Injury is significantly driven by markers of hemodynamic instability, tubular injury and myocardial damage
Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
Remdesivir improves biomarkers associated with disease severity in COVID-19 patients treated in an outpatient setting
Little is known about the impact of antiviral treatments on biomarkers of COVID-19 severity. Here, we measured biomarkers during the course of COVID-19 in high-risk non-hospitalized patients treated with or without the antiviral remdesivir.
Exploring the changes in human salivary proteome after intraglandular treatment with mesenchymal stem cell treatment in previous cancer patients with salivary gland damage